Pear Therapeutics (PEAR) Stock Analysis

What Pear Therapeutics does

Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.

Key metrics

ETFs linked to PEAR

Broad-market and Healthcare sector ETFs an investor holding Pear Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PEAR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Pear Therapeutics?

Pear Therapeutics trades under the ticker PEAR on NASDAQ.

Which exchange is PEAR listed on?

PEAR is listed on NASDAQ.

What sector does Pear Therapeutics operate in?

Pear Therapeutics is classified in the Healthcare sector (Medical - Healthcare Information Services industry).

How can PortView help analyze PEAR in a portfolio?

PortView shows PEAR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.